Approval · Notice of Compliance 14480 · 2013
JAMP-VANCOMYCIN: Notice of Compliance 14480
Issued June 21, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14480
- Date
- June 21, 2013
- Company
- JAMP Pharma CorporationBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative licensing agreement between two companies
- Therapeutic class
- Antibiotic
- Canadian reference product
- VANCOCIN (Merus Labs Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JAMP-VANCOMYCIN | 02407744 | Marketed |
| JAMP-VANCOMYCIN | 02407752 | Marketed |
Medicinal ingredients
- VANCOMYCIN HYDROCHLORIDE 125 MG per CAP
- VANCOMYCIN HYDROCHLORIDE 250 MG per CAP